Literature DB >> 7902705

Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.

M Garrigos1, J Belehradek, L M Mir, S Orlowski.   

Abstract

Purified membrane vesicles were prepared from Chinese Hamster lung fibroblasts expressing high amounts of P-glycoprotein (P-gp), which is responsible for the multidrug resistance. P-gp ATPase activity, characterized in the presence or absence of verapamil, had a Michaelian behavior for its MgATP dependence. Thus only one MgATP molecule should be sufficient for the catalytic cycle. With increasing verapamil concentrations, a bell-shape curve was observed for ATPase activity, with half-activation and -inhibition concentrations of 1.2 microM and 490 microM, respectively. No cooperativity for verapamil was detected. These results strongly suggest that P-gp functions as an active transporter, with a coupling stoichiometry of one MgATP molecule hydrolysed for one verapamil molecule transported.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902705     DOI: 10.1006/bbrc.1993.2355

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Recognition of sulfonylurea receptor (ABCC8/9) ligands by the multidrug resistance transporter P-glycoprotein (ABCB1): functional similarities based on common structural features between two multispecific ABC proteins.

Authors:  Anis Bessadok; Elisabeth Garcia; Hélène Jacquet; Solenne Martin; Alexia Garrigues; Nicolas Loiseau; François André; Stéphane Orlowski; Michel Vivaudou
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.

Authors:  Samy A F Morad; Traci S Davis; Matthew R MacDougall; Su-Fern Tan; David J Feith; Dhimant H Desai; Shantu G Amin; Mark Kester; Thomas P Loughran; Myles C Cabot
Journal:  Biochem Pharmacol       Date:  2017-02-09       Impact factor: 5.858

Review 3.  Using purified P-glycoprotein to understand multidrug resistance.

Authors:  A B Shapiro; V Ling
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

4.  Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.

Authors:  F J Sharom; X Yu; J W Chu; C A Doige
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

5.  Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.

Authors:  S Orlowski; L M Mir; J Belehradek; M Garrigos
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

6.  Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.

Authors:  Ivan Bello; Milena Salerno
Journal:  Cell Stress Chaperones       Date:  2015-01-16       Impact factor: 3.667

7.  The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.

Authors:  Alexia Garrigues; Alexandre E Escargueil; Stephane Orlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

8.  Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.

Authors:  C Pascaud; M Garrigos; S Orlowski
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

9.  UCP2 - Taking the heat out of P-glycoprotein?

Authors:  Richard Callaghan; Mary Board
Journal:  Cancer Drug Resist       Date:  2021-06-19

10.  Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.

Authors:  Mi Sun Jin; Michael L Oldham; Qiuju Zhang; Jue Chen
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.